Abstract
Background Physical activity (PA) is a protective factor against amyloid-β (Aβ) accumulation in adults at risk for Alzheimer’s disease (AD). This association, however, may differ by apolipoprotein E (APOE) genotype. This work examines interactions between age, PA, and neuropathology-based genetic risk for AD (APOEnp) on Aβ burden in cortical regions sensitive to its accumulation.
Materials and Methods Included were 388 cognitively unimpaired, older (mean age ± SD = 68.10 ± 7.09; 66% female) participants from the Wisconsin Registry for Alzheimer’s Prevention (WRAP) study. The cohort was enriched with both family history of AD at enrollment and a higher overall prevalence of APOE ε4 allele carriage than typically observed in the general population. PA was assessed using a self-reported questionnaire. Aβ burden was measured using Pittsburg Compound B (11C-PiB) PET imaging, which allowed us to derive volume corrected distribution volume ratio (DVR) maps from nine bilateral regions of interest (ROIs) and a global cortical composite score. Linear regression models examined the interactions between age, PA, and APOEnp on Aβ burden. Finally, APOEnp scores were aggregated according to estimated risk to illustrate the differential effects between active (weekly moderate PA > 150 minutes) and inactive individuals.
Results Three-way interactions (Age × PA × APOEnp) were significant (all P’s ≤ 0.05) for the global cortical composite and six of the examined ROIs (the PPC, ACC, mOFC, SMG, MTG, and STG). Models stratified by APOEnp and PA showed greater levels of age-related Aβ accumulation in each of these ROIs, with the greatest effects in inactive participants with high APOEnp scores.
Conclusion Individuals with high APOEnp scores who concomitantly engage in suboptimal weekly moderate-intensity PA have greater Aβ burden. These findings underscore how both PA and APOEnp haplotype play intersect in modifying age-related Aβ burden in brain regions susceptible to its deposition in cognitively unimpaired, older adults at risk for AD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by National Institute on Aging grants R01 AG062167 (O.C.O.), R01 AG077507 (O.C.O.), R01 AG085592 (O.C.O.), R01 AG027161 (S.C.J.), R01 AG021155 (S.C.J.), R01 AG054059 (C.E.G.) and P30 AG062715 (S.A.); and a Clinical and Translational Science Award (UL1RR025011) to the University of Wisconsin, Madison. This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P50 HD105353) and a NIH High-End Instrumentation grant (S10 OD030415).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of Wisconsin gave ethical approval for this work and approved all study procedures. All study participants provided signed informed consent before participation.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
Request for the data utilized in this study may be directed to the corresponding authors.
